Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial
Bayer's KERENDIA Priority Review Highlights Cardiorenal Opportunity And Pipeline Execution Risk
Pulmonary Arterial Hypertension Market Outlook Shows Strong Upward Trend at a CAGR of 6.7% During the Study Period (2022-2036) Supported by New Clinical Developments | DelveInsight
Bayern Munich hire former 1859+1 Munich player Lars Bender as U-17 head coach, Leonard Haas moves up
Evogene Ltd. (NASDAQ:EVGN) Q1 2026 Earnings Call Transcript
Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer
Nocopi Technologies Expands Operations with Acquisition of Polymeric and Appointment of Industry Executive
Bayer says FDA grants priority review designation for finerenone
Bayer's KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type 1 Diabetes and Chronic Kidney Disease
Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist
Bayer revises loyalty program requirements following DOJ scrutiny
Top cases on the United States Supreme Court's docket
Bayer (XTRA:BAYN) Valuation Check As Twin FDA Priority Reviews Highlight Pipeline Progress
Dhanuka Agritech Ltd (BOM:507717) Q4 2026 Earnings Call Highlights: Navigating Growth Amidst ...
Bayer bets big on 'self-care' market to deepen India play - The Economic Times
Bayer Granted Priority Review For Asundexian In Secondary Stroke Prevention
Bayer (BAYRY) Receives FDA Priority Review for Asundexian in Str
Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack | Morningstar
Bayer (BAYRY) Settles Toxic Contamination Claims for $133M
Bayer agrees to pay $133 million for PCB cleanup in two states
Bayer Gets FDA Priority Review For Hyrnuo In First-Line HER2-Mutated Lung Cancer
Assessing Bayer (XTRA:BAYN) Valuation After Mixed Share Performance And Profit Recovery Hopes
Xabi Alonso Appointed Chelsea Manager on Four-Year Deal
Bayer Aktiengesellschaft Backs Crop Science Targets as Seed Pipeline Gains Momentum
Alonso deal nears - have your say
ANGELA HUFFMAN: Pesticide Giants Want Special Treatment In Washington. Farmers Want Their Rights.
AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer
Bayer Introduces Midol® in Motion, Empowering Menstruators to Find PMS Relief Through Movement | Morningstar
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study
Alembic Pharma Gets USFDA Nod for Prostate Cancer Drug
Bayer (XTRA:BAYN) Swings To €2.81 EPS Profit And Tests Long‑Running Bearish Narratives
Bayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural Communities | Morningstar
Bayer's FarmRise app reaches 5 million users
Farm Hands on the Potomac: Adesina joins BGR Group, Newman departs IDFA for FCA, Trujillo joins NCBA
SAP Sapphire 2026: Credible Vision, Real Concentration Risk
Bayer AG (BAYRY) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amidst Cash Flow Challenges
Investor sues after $150M San Antonio mixed-use project fizzles
Q1 2026 Bayer AG Earnings Call Transcript
European Markets Decline Amid Political Turmoil and Oil Price Surge
Stellarix Identifies Major Strategic Shifts as Agrochemical Leaders Bet on Integrated Solutions
European Markets Decline Amid Political Uncertainty and Earnings Reports
Bayer and the National Hospital of Obstetrics and Gynaecology sign deal to improve women"s healthcare
Bayer profit up on seed business but glyphosate sales struggle
Bayer Q1 Profit Jumps; Confirms Full-Year Outlook At Constant Currencies
Sowing Innovation: The Bayer and Microsoft 2026 Digital Ecosystem
Bayer, bp Sign Deal to Scale Biofuel Crop Production
Advances in diagnosing and treating diabetic retinopathy
A Look At Bayer (XTRA:BAYN) Valuation As Cardiac Amyloidosis Trial Hits Phase III Milestone
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial
Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial
Is Bayer (XTRA:BAYN) Offering Opportunity After 54.3% One Year Share Price Gain?
Bayer Crop Science and bp partner to expand camelina market for biofuels
Corteva's Vylor Spinoff And Bayer Deal Reframe Valuation Story
Can India's rice farmers reap from US$30 million Amazon carbon credit deal?
Gossip: Leverkusen also keen on Esteve
Gossip: Leverkusen also keen on Eseteve
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial
Bayer Reshapes Pharma And Crop Science With Perfuse Deal And bp Alliance
Investigational PET Tracer Iodine 124 Evuzamitide from Bayer Met Primary Endpoints in Phase III Study in Patients Suspected to Have Cardiac Amyloidosis | Morningstar
Protect Soil, Farming and Health from Adverse Impacts of Chemical Pesticides | Countercurrents
Bayer bets on mid-stage vision drug with $2.4 Bn Perfuse Therapeutics buyout
Avalo's IL-1 beta-targeting abdakibart scores in HS phase II | BioWorld
Bayer and bp Form Strategic Alliance to Jointly Scale Camelina as Intermediate Crop for Biofuels
Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal
Bayer Buys US Drugmaker Perfuse for as Much as $2.45 Billion (1)
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion | Morningstar
Bayer To Acquire Perfuse Therapeutics; Expands Ophthalmology Pipeline
Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline | Morningstar
Bayer buying Perfuse for $300M up front in potential $2.45B deal | BioWorld
Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Taiwan News | May. 6, 2026 04:05
Hurzeler expected to sign new Albion deal 'shortly' - Yahoo Sports
Analysis-Trump's Germany troop cuts show limits of NATO efforts to keep US on board - Yahoo News UK
U.S. Supreme Court divided by lawsuits over Roundup, cancer
Driving climate-smart agriculture: John Kanyingi's vision for East Africa's farmers
Assessing Bayer (XTRA:BAYN) Valuation After New OCEANIC STROKE Phase III Asundexian Data Spotlight
Is It Too Late To Consider Bayer (XTRA:BAYN) After A 59.8% One-Year Surge?
Consumer product safety recall roundup for May 1, 2026
Nearly 800K Afrin bottles recalled after faulty packaging causes child safety risk
Are there new products coming down the line?
Bayer recalls nearly 800,000 Afrin bottles over child safety risk | Fox Business
Nasal spray sold nationwide recalled by Bayer. See affected products
House strips MAHA-hated pesticide provisions from farm bill
Bayer backs Norwich Research Park global scale-up programme for agri-food biotech businesses
Regeneron Reports First Quarter 2026 Financial and Operating Results | Taiwan News | Apr. 29, 2026 18:30
Edmond Tapsoba nearing contract extension at Bayer Leverkusen
AOC Grills Trump Cabinet Member on Major 'Conflict of Interest' In Heated Hearing Exchange
Supreme Court Hears Case On How To Label Risks of Popular Weed Killer
Thousands of Roundup Lawsuits Hinge on Bayer's US Supreme Court Case
Bayer's strongest-ever pharma portfolio and promising pipeline drive future growth
European Markets Rise Amid Earnings Reports and Geopolitical Tensions
Supreme Court hears arguments on how to label risks of popular weedkiller | Fox News Video
Bayer outlines growth path to 2030 driven by AI and pharma innovation
Bayer News
Markets.com Review 2026: Complete Account Opening Guide, Deposit, Withdrawal & Demo Test
S&P 500 Analysis: S&P 500 Trading Landscape Changes as Wall Street Reacts to Economic Data
Rivian Stock Price Prediction 2030: What South African Investors Need to Know about RIVN Stock?
AED/USD Exchange Rate Analysis: Why the AED is One of the Most Stable Currencies in Forex Right Now?
Latest news
Show more
UAE’s Explosive AI Growth: UAE Tops Global AI Adoption for Third Straight Quarter at 70.1% Usage Rate
Gold Price Today, May 27: XAU/USD Holds Steady Around $4,510 as Traders Eye Fed Signals and Iran Talks
Gold Price Today, May 26: XAU/USD Holds Near $4,540 as Markets Weigh Fed Signals
Fed Leadership Change: Kevin Warsh Takes Over Federal Reserve at Critical Economic Moment
Gold Price Today, May 25: XAU/USD Opens Near $4,523 After Friday's Close at $4,509 on US-Iran Developments
